Adma Biologics (ADMA) Change in Inventory (2011 - 2025)
Adma Biologics' (ADMA) quarterly Change in Inventory came in at $9.8 million in Q4 2025, up 725.67% YoY from $1.2 million in Q4 2024, and up 88.31% on a QoQ basis from $5.2 million in Q3 2025.
Adma Biologics (ADMA) Change in Inventory (2011 - 2025) Analysis & Trends
Adma Biologics (ADMA) has 13 years of Change in Inventory data on file, last reported at $9.8 million in Q4 2025.
- Quarterly Change in Inventory rose 725.67% year-over-year to $9.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.2 million (up 1456.42% YoY) and the FY2025 annual result came in at $36.2 million, up 1456.42% from the prior year.
- Change in Inventory rose to $9.8 million in Q4 2025, from $5.2 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $19.3 million in Q2 2025 to a low of -$8.0 million in Q3 2024.
- A 5-year average of $6.2 million and a median of $5.4 million in 2021 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory soared 2571.53% — and 2024, when it tumbled 699.48%.
- Tracing ADMA's Change in Inventory over 5 years: stood at $10.6 million in 2021, then tumbled by 96.54% to $366457.0 in 2022, then soared by 2571.53% to $9.8 million in 2023, then plunged by 116.0% to -$1.6 million in 2024, then surged by 725.67% to $9.8 million in 2025.
- The last three Change in Inventory figures came in at $9.8 million (Q4 2025), $5.2 million (Q3 2025), and $19.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.80 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | 19.28 Mn |
| Jun 30, 2025 | 19.28 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | -1.57 Mn |
| Dec 31, 2024 | -1.57 Mn |
| Sep 30, 2024 | -8.01 Mn |
| Sep 30, 2024 | -8.01 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 9.79 Mn |
| Dec 31, 2023 | 9.79 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.34 Mn |